Page last updated: 2024-11-13

onjisaponin b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

onjisaponin B: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

senegin III : A triterpenoid saponin isolated from Polygala senega var latifolia and has been shown to exhibit hypoglycemic activity. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID21669942
CHEBI ID177680
CHEBI ID66469
SCHEMBL ID4097653
MeSH IDM0449838

Synonyms (17)

Synonym
onjisaponin b
CHEBI:177680
senegin iii
C17760
3-o-beta-d-glucopyranosylpresenegenin-28-o-[2-[beta-d-galactopyranosyl(1->4)-beta-d-xylopyranosyl(1->4)-alpha-l-rhamnopyranosyl]]-3-(alpha-l-rhamnopyranosyl)-4-[4'-methoxycinnamoyl]-beta-d-fucopyranoside
6-deoxy-alpha-l-mannopyranosyl-(1->3)-[beta-d-galactopyranosyl-(1->4)-beta-d-xylopyranosyl-(1->4)-6-deoxy-alpha-l-mannopyranosyl-(1->2)]-6-deoxy-1-o-[(2beta,3beta)-3-(beta-d-glucopyranosyloxy)-2,23,27-trihydroxy-23,28-dioxoolean-12-en-28-yl]-4-o-[3-(4-met
CHEBI:66469
SCHEMBL4097653
35906-36-6
AC-35037
AKOS030530165
sinegin 3
Q27135064
CS-0018620
HY-N2099
onjisaponin b; senegin iii
MS-32199
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
triterpenoid saponinA terpene glycoside in which the terpene moiety is a triterpenoid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's6 (66.67)24.3611
2020's2 (22.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.26

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.26 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index5.38 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.26)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]